Click here to read more about OCTOPUS at the MS Frontiers conference in July held at Liverpool.
Trial news
Recruitment News!
We have now reached 277 participants randomised and 375 participants screened meaning we have recruited 74% of our goal for analysis stage 1 (375)!
